rs74478954

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_001384732.1(CPLANE1):​c.3795T>A​(p.Val1265Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00564 in 1,610,988 control chromosomes in the GnomAD database, including 116 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 49 hom., cov: 32)
Exomes 𝑓: 0.0046 ( 67 hom. )

Consequence

CPLANE1
NM_001384732.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.01

Publications

4 publications found
Variant links:
Genes affected
CPLANE1 (HGNC:25801): (ciliogenesis and planar polarity effector complex subunit 1) The protein encoded by this gene has putative coiled-coil domains and may be a transmembrane protein. Defects in this gene are a cause of Joubert syndrome (JBTS). [provided by RefSeq, May 2012]
CPLANE1 Gene-Disease associations (from GenCC):
  • Joubert syndrome 17
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, ClinGen, G2P, Illumina, Labcorp Genetics (formerly Invitae)
  • orofaciodigital syndrome type 6
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 5-37195874-A-T is Benign according to our data. Variant chr5-37195874-A-T is described in ClinVar as Benign. ClinVar VariationId is 158033.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0155 (2366/152236) while in subpopulation AFR AF = 0.0469 (1948/41530). AF 95% confidence interval is 0.0452. There are 49 homozygotes in GnomAd4. There are 1135 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 49 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CPLANE1NM_001384732.1 linkc.3795T>A p.Val1265Val synonymous_variant Exon 21 of 53 ENST00000651892.2 NP_001371661.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CPLANE1ENST00000651892.2 linkc.3795T>A p.Val1265Val synonymous_variant Exon 21 of 53 NM_001384732.1 ENSP00000498265.2

Frequencies

GnomAD3 genomes
AF:
0.0155
AC:
2362
AN:
152118
Hom.:
49
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0469
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00694
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0101
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00331
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.00685
AC:
1700
AN:
248134
AF XY:
0.00663
show subpopulations
Gnomad AFR exome
AF:
0.0485
Gnomad AMR exome
AF:
0.00504
Gnomad ASJ exome
AF:
0.000501
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000926
Gnomad NFE exome
AF:
0.00393
Gnomad OTH exome
AF:
0.00548
GnomAD4 exome
AF:
0.00461
AC:
6720
AN:
1458752
Hom.:
67
Cov.:
30
AF XY:
0.00482
AC XY:
3495
AN XY:
725652
show subpopulations
African (AFR)
AF:
0.0502
AC:
1671
AN:
33276
American (AMR)
AF:
0.00542
AC:
239
AN:
44058
Ashkenazi Jewish (ASJ)
AF:
0.000423
AC:
11
AN:
26030
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39528
South Asian (SAS)
AF:
0.0101
AC:
867
AN:
85500
European-Finnish (FIN)
AF:
0.000131
AC:
7
AN:
53362
Middle Eastern (MID)
AF:
0.0217
AC:
125
AN:
5748
European-Non Finnish (NFE)
AF:
0.00306
AC:
3399
AN:
1111032
Other (OTH)
AF:
0.00664
AC:
400
AN:
60218
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
309
617
926
1234
1543
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0155
AC:
2366
AN:
152236
Hom.:
49
Cov.:
32
AF XY:
0.0152
AC XY:
1135
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0469
AC:
1948
AN:
41530
American (AMR)
AF:
0.00693
AC:
106
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00995
AC:
48
AN:
4824
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10616
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.00331
AC:
225
AN:
68012
Other (OTH)
AF:
0.0132
AC:
28
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
116
232
347
463
579
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00646
Hom.:
1
Bravo
AF:
0.0177
Asia WGS
AF:
0.00289
AC:
10
AN:
3476
EpiCase
AF:
0.00369
EpiControl
AF:
0.00645

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 23, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Joubert syndrome 17 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
5.2
DANN
Benign
0.80
PhyloP100
1.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.25
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.25
Position offset: 3

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74478954; hg19: chr5-37195976; API